Medical Health Cluster

Reporte covid19

Los anticuerpos contra el Covid desaparecen a los 7 meses de pasarlo en casi la mitad de infectados

Ha quedado demostrado que tras pasar la enfermedad del Covid-19, se forman anticuerpos que protegen de la enfermedad. Sin embargo, estos anticuerpos tienen un tiempo establecido de duracion. Los anticuerpos contra el Covid-19 se vuelven indetectables en las pruebas serológicas en un 43,3% de los pacientes transcurridos siete meses desde la infección, según […]

Read More

CDC Recommends Hep B Vaccination for Most Adults

On March 31, the Centers for Disease Control and Prevention (CDC) recommended that all adults aged 19-59 years receive a vaccination for hepatitis B. It also added that adults aged 60 years or older without known risk factors for hepatitis B may get vaccinated. The agency earlier recommended the vaccination for all infants and children […]

Read More

COVID-19: el resumen semanal (25 al 31 de marzo de 2022)

China reafirma su política de “COVID-19 cero” y dispone su mayor confinamiento desde 2020 Cuando a comienzos de 2020 China confinó a los 11 millones de residentes de Wuhan durante 76 días, el resto del mundo, hasta entonces libre del nuevo virus, miró asombrado. Dos años después la situación se […]

Read More

Pushed to Their Limits, 1 in 5 Physicians Intends to Leave Practice

On the same day in March 2020 that President Donald Trump declared the COVID-19 pandemic a national emergency, researchers at the Larry A. Green Center in Virginia launched an ongoing survey of COVID-19’s effects on primary care practices. Over the past 2 years, more than 36 000 survey responses from clinicians across the […]

Read More

Immune System Memory Persists a Year After COVID-19

A year after infection with the coronavirus, when antibodies in the blood are barely detectable, the immune system continues to “remember” the virus and should respond to some extent upon re-encountering it, a study from China suggests. Researchers studied 141 people infected with the virus in the first half of […]

Read More

Effect of Early Treatment with Ivermectin among Patients with Covid-19

The efficacy of ivermectin in preventing hospitalization or extended observation in an emergency setting among outpatients with acutely symptomatic coronavirus disease 2019 (Covid-19), the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is unclear. METHODS We conducted a double-blind, randomized, placebo-controlled, adaptive platform trial involving symptomatic SARS-CoV-2–positive adults […]

Read More

Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine

BACKGROUND Active immunization with the BNT162b2 vaccine (Pfizer–BioNTech) has been a critical mitigation tool against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the coronavirus disease 2019 (Covid-19) pandemic. In light of reports of waning protection occurring 6 months after the primary two-dose vaccine series, data are needed on […]

Read More

Vaccines Remain Effective against BA.2, but Protection from Infection Wanes over Time

The Omicron subvariant BA.2 is replacing its sister version, BA.1, as the dominant form of SARS-CoV-2 in many countries, which has led scientists to wonder whether the COVID-19 pandemic is about to throw these regions into disarray yet again. But a study published on 13 March shows that mRNA vaccines offer a similar degree […]

Read More

COVID-19: el resumen semanal (11 al 17 de marzo de 2022)

Mortalidad récord en Hong Kong y millones de confinados en China Hasta hace algunas semanas Hong Kong era un territorio casi liberado de COVID-19, con solo 12.000 casos y apenas 220 decesos para fines de 2021 (sobre una población de casi 7,5 millones). Pero desde febrero los casos estallaron, con más de […]

Read More